Game-changer in Spatial Biology
Lunaphore was developing an immunohistochemical testing procedure that uses microfluidic systems to achieve faster, more precise analysis of tumor tissue. In addition, Lunaphore enabled digital pathology by integrating imaging systems such as a microscope with sequential data extraction. Lunaphore was acquired by the global life sciences company Bio-Techne Corporation (NASDAQ:TECH) in 2023.